Molecular allergy diagnosis for the clinical characterization of asthma
The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Abstract
Defining the allergen sensitization of a patient with asthma at the molecular level by measuring specific IgE to purified natural or recombinant allergens can improve diagnostic accuracy and improve asthma phenotyping. Molecular diagnosis is possible thanks to the specificity of some markers of species-specific sensitization and resolve cross-reactivity phenomena from a true co-sensitization. None of this precision is possible with conventional allergy tests, and such information will eventually give clinicians the possibility to individualize the actions taken, including indications on reducing targeted-allergen exposure or selection of suitable allergens for specific immunotherapy, thereby increasing the safety and efficacy of immunotherapy. Nevertheless, all in vitro tests should be assessed alongside clinical history, as allergen sensitization does not necessarily imply clinical responsiveness.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Overall, MD can potentially improve diagnostic accuracy (specificity), distinguish cross-reactivity phenomena from true co-sensitization, resolve low-risk markers from high-risk markers of disease activity, and may improve the indication and selection of suitable allergens for AIT when compared to diagnosis based on SPT and/or sIgE determination with raw commercial extracts.980-984”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [982]
In the citing paper
“Overall, MD can potentially improve diagnostic accuracy (specificity), distinguish cross-reactivity phenomena from true co-sensitization, resolve low-risk markers from high-risk markers of disease activity, and may improve the indication and selection of suitable allergens for AIT when compared to diagnosis based on SPT and/or sIgE determination with raw commercial extracts.980-984”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [982]
In the citing paper
“Overall, MD can potentially improve diagnostic accuracy (specificity), distinguish cross-reactivity phenomena from true co-sensitization, resolve low-risk markers from high-risk markers of disease activity, and may improve the indication and selection of suitable allergens for AIT when compared to diagnosis based on SPT and/or sIgE determination with raw commercial extracts.980-984”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [982]
In the citing paper
“Overall, MD can potentially improve diagnostic accuracy (specificity), distinguish cross-reactivity phenomena from true co-sensitization, resolve low-risk markers from high-risk markers of disease activity, and may improve the indication and selection of suitable allergens for AIT when compared to diagnosis based on SPT and/or sIgE determination with raw commercial extracts.980-984”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [982]
Citations
Cites
Asthma phenotypes: the evolution from clinical to molecular approaches
Wenzel, S. E. (2012) · Nature Medicine · doi:10.1038/nm.2678 · Cited by 2,412 · cited 1×
“Conversely, determination of specific IgE to allergens may better address the allergic basis of asthma, the most common asthma phenotype [17], and can be important for recommending allergen-avoidance education and identifying patients for specific therapies such as immunotherapy.”
BackgroundAssociation of Asthma with Serum IgE Levels and Skin-Test Reactivity to Allergens
Burrows, B., Martinez, F. D., Halonen, M., Barbee, R. A., & Cline, M. G. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902023200502 · Cited by 1,659 · cited 1×
“Though previous population-based studies have shown that asthma is closely and significantly related to total serum IgE levels [15], the diagnostic utility of this correlation is low.”
BackgroundBusse, W., Corren, J., Lanier, B. Q., McAlary, M., Fowler-Taylor, A., Cioppa, G. D., van As, A., & Gupta, N. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.117880 · Cited by 1,307 · cited 1×
“During this time, omalizumab, a recombinant, humanized, monoclonal antibody that binds specifically to freely circulating IgE, was approved for treatment of moderateto-severe allergic asthma [22].”
BackgroundAgarwal, R., Chakrabarti, A., Shah, A., Gupta, D., Meis, J. F., Guleria, R., Moss, R., Denning, D. W., & ABPA complicating asthma ISHAM working group (2013) · Clinical & Experimental Allergy · doi:10.1111/cea.12141 · Cited by 896
The clinical spectrum of pulmonary aspergillosis
Kosmidis, C., & Denning, D. W. (2015) · Thorax · doi:10.1136/thoraxjnl-2014-206291 · Cited by 850
Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment
Hiller, R., Laffer, S., Harwanegg, C., Huber, M., Schmidt, W. M., Twardosz, A., Barletta, B., Becker, W. M., Blaser, K., Breiteneder, H., et al. (2002) · The FASEB Journal · doi:10.1096/fj.01-0711fje · Cited by 440 · cited 1×
“This platform is a microarray-based assay (Immuno Solid phase Allergen Chip (ISAC) , a miniaturized immunoassay platform in which allergen components are immobilized in a microarray [8].”
MethodRadauer, C., Bublin, M., Wagner, S., Mari, A., & Breiteneder, H. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.01.025 · Cited by 429 · cited 1×
“Almost anything containing proteins can be an allergen source, although it has become clear that most allergens and their components belong to a limited number of protein families [6].”
BackgroundBousquet, J., Cabrera, P., Berkman, N., Buhl, R., Holgate, S., Wenzel, S., Fox, H., Hedgecock, S., Blogg, M., & Cioppa, G. D. (2005) · Allergy · doi:10.1111/j.1398-9995.2004.00770.x · Cited by 401 · cited 1×
“During the last decade, IgE has become a pharmacologic target in patients with severe allergic asthma not adequately controlled by high doses of inhaled corticosteroids and long-acting b-agonists [21].”
BackgroundThe Role of Immunoglobulin E in Allergy and Asthma
PLATTS-MILLS, T. A. E. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.supplement_1.2103024 · Cited by 362 · cited 1×
“Re-exposure of these cells to the allergen causes cross-linking of receptor-bound IgE, producing the immediate release of histamine and other granular-associated preformed mediators and also causes synthesis and release of lipid mediators, including leukotrienes and, later, prostaglandins [14].”
BackgroundBush, R. K., & Prochnau, J. J. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.11.023 · Cited by 352 · cited 1×
“Alternaria (Alternaria alternata) Sensitivity to Alternaria alternata, a Pleosporaceae mould, is a risk factor for development, persistence and exacerbation of asthma in both children and adults [53].”
Background
Research works printed but not linked: 7
- Valenta R, 2007, J Invest Allergol Clin Immunol, 17, 36
- Cabrera-Freitag P, 2011, J Investig Allergol Clin Immunol, 21, 414
- Fernández-Caldas E, 2008, Clin Allergy Immunol, 21, 161
- Cabanas R, 2000, J Investig Allergol Clin Immunol, 10, 71
- Cabañes N, 2012, J Investig Allergol Clin Immunol, 22, 313
- Justicia JL, 2007, J Investig Allergol Clin Immunol, 17, 386
- 10.1016/j.anai.2011.03.017 · DOI
Cited by
International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
Wise, S. K., Lin, S. Y., Toskala, E., Orlandi, R. R., Akdis, C. A., Alt, J. A., Azar, A., Baroody, F. M., Bachert, C., Canonica, G. W., et al. (2018) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22073 · Cited by 557
Self-citationInternational consensus statement on allergy and rhinology: Allergic rhinitis – 2023
Wise, S. K., Damask, C., Roland, L. T., Ebert, C., Levy, J. M., Lin, S., Luong, A., Rodriguez, K., Sedaghat, A. R., Toskala, E., et al. (2023) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23090 · Cited by 507
Self-citationAllergen Immunotherapy: Current and Future Trends
Pavón-Romero, G. F., Parra-Vargas, M. I., Jiménez, F. R., Melgoza-Ruiz, E., Serrano-Pérez, N. H., & Teran, L. M. (2022) · Cells · doi:10.3390/cells11020212 · Cited by 139
Clinical relevance of molecular diagnosis in pet allergy
Uriarte, S. A., & Sastre, J. (2016) · Allergy · doi:10.1111/all.12917 · Cited by 69
Self-citationMuthu, V., Singh, P., Choudhary, H., Sehgal, I. S., Dhooria, S., Prasad, K. T., Aggarwal, A. N., Garg, M. K., Chakrabarti, A., & Agarwal, R. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.08.041 · Cited by 59
Metadata
- Authors
- Sastre-Ibañez, M., & Sastre, J.
- Affiliations
- 1Allergy Department, Fundación Jiménez Díaz and CIBER de Enfermedades Respiratorias (CIBERES, Institute Carlos III, Ministry of Economy and Competitiveness) Madrid, Universidad Autónoma de Madrid, Madrid, Spain
- Venue
- Expert Review of Molecular Diagnostics
- Publisher
- Informa UK Limited
- Published
- 2015-04-12
- Volume
- 15
- Issue
- 6
- Pages
- 789-799
- ISSN
- 1473-7159 (ISSN-L)
- 1744-8352
- OpenAlex
- W2110221554
- Cited by
- 14
- References
- 84
- Citations by year
- 2026: 1 · 2023: 2 · 2022: 2 · 2021: 1 · 2019: 3 · 2018: 2 · 2017: 1 · 2016: 2
- FWCI
- 0.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Expert Review of Molecular Diagnostics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Immunology and Allergy › Allergic Rhinitis and Sensitization
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Occupational exposure and asthma
- Keywords
- asthma, specific IgE, allergen sensitization, recombinant allergens, cross-reactivity, asthma phenotyping, allergen immunotherapy
- MeSH terms
- Allergens, Animals, Asthma, Humans, Hypersensitivity, Immunoglobulin E, Immunotherapy, Molecular Diagnostic Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Molecular allergy diagnosis for the clinical characterization of asthma. https://app.cochat.ai/papers/10.1586/14737159.2015.1036745
- The paper
- Sastre-Ibañez, M., & Sastre, J. (2015). Molecular allergy diagnosis for the clinical characterization of asthma. Expert Review of Molecular Diagnostics. https://doi.org/10.1586/14737159.2015.1036745
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.